MarketBeat on MSN
Hims & Hers: From Viral Ad to Volatile Stock
Hims & Hers Health's (NYSE: HIMS) share price has surged recently, climbing above $60 and creating new 52-week and all-time record highs for the company. This significant increase in Hims & Hers ...
This week, Hims & Hers’ (NYSE:HIMS) recent Super Bowl ad campaign was at least twice mentioned by Marty Makary, Commissioner of the U.S. Food and Drug Administration (FDA) as a glaring example of how ...
The Food and Drug Administration building is seen on Dec. 10, 2020, in Silver Spring, Md. (AP Photo/Manuel Balce Ceneta, File) WASHINGTON (AP) — For the first time, federal health officials are taking ...
For the first time, federal health officials are taking aim at telehealth companies promoting unofficial versions of prescription drugs — including popular weight loss medications — as part of the ...
The advertisement failed to adequately disclose the drugs' potential side effects, violating rules that require prescription medication ads to present a balanced view of benefits and risks, Reuters ...
Hims & Hers Health's ads have been getting attention from the Trump administration. President Donald Trump's administration on Tuesday rolled out a memorandum aimed at limiting direct-to-consumer ...
WASHINGTON — For the first time, federal health officials are taking aim at telehealth companies promoting unofficial versions of prescription drugs — including popular weight loss medications — as ...
WASHINGTON — For the first time, federal health officials are taking aim at telehealth companies promoting unofficial versions of prescription drugs — including popular weight loss medications — as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results